Teprotumumab for Graves' orbitopathy and ototoxicity: moving problems from eyes to ears?

被引：27
作者：
Bartalena, L. [1 ]
Marino, M. [2 ]
Marcocci, C. [2 ]
Tanda, M. L. [1 ]
机构：
[1] Univ Insubria, Dept Med & Surg, Endocrinol, Via Guicciardini 9, I-21100 Varese, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
来源：
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 2022年 / 45卷 / 07期
关键词：
Teprotumumab; Graves' orbitopathy; Thyroid-eye disease; Hearing loss; Inflammatory bowel disease; Amyloid encephalopathy; HEARING-LOSS; DISEASE;
D O I：
10.1007/s40618-022-01791-w
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1455 / 1457
页数：3
相关论文
共 19 条
[1]   New-Onset of Inflammatory Bowel Disease in a Patient Treated With Teprotumumab for Thyroid Associated Ophthalmopathy [J].
Ashraf, Davin C. ;
Jankovic, Ivana ;
El-Nachef, Najwa ;
Winn, Bryan J. ;
Kim, Grace E. ;
Kersten, Robert C. .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2021, 37 (05) :E160-E164
[2]   The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy [J].
Bartalena, L. ;
Kahaly, G. J. ;
Baldeschi, L. ;
Dayan, C. M. ;
Eckstein, A. ;
Marcocci, C. ;
Marino, M. ;
Vaidya, B. ;
Wiersinga, W. M. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (04) :G43-G67
[3]   Graves' Ophthalmopathy [J].
Bartalena, Luigi ;
Tanda, Maria Laura .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) :994-1001
[4]   Teprotumumab and Hearing Loss: Case Series and Proposal for Audiologic Monitoring [J].
Belinsky, Irina ;
Creighton, Francis X., Jr. ;
Mahoney, Nicholas ;
Petris, Carisa K. ;
Callahan, Alison B. ;
Campbell, Ashley A. ;
Kazim, Michael ;
Lee, H. B. Harold ;
Yoon, Michael K. ;
Glass, Lora R. Dagi .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 38 (01) :73-78
[5]   Sensorineural Hearing Loss After Teprotumumab Therapy for Thyroid Eye Disease: A Case Report [J].
Ding, Andy S. ;
Mahoney, Nicholas R. ;
Campbell, Ashley A. ;
Creighton, Francis X. .
OTOLOGY & NEUROTOLOGY, 2022, 43 (02) :E148-E152
[6]   Teprotumumab for the Treatment of Active Thyroid Eye Disease [J].
Douglas, R. S. ;
Kahaly, G. J. ;
Patel, A. ;
Sile, S. ;
Thompson, E. H. Z. ;
Perdok, R. ;
Fleming, J. C. ;
Fowler, B. T. ;
Marcocci, C. ;
Marino, M. ;
Antonelli, A. ;
Dailey, R. ;
Harris, G. J. ;
Eckstein, A. ;
Schiffman, J. ;
Tang, R. ;
Nelson, C. ;
Salvi, M. ;
Wester, S. ;
Sherman, J. W. ;
Vescio, T. ;
Holt, R. J. ;
Smith, T. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (04) :341-352
[7]   Teprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial Investigators [J].
Douglas, Raymond S. ;
Wang, Yao ;
Dailey, Roger A. ;
Harris, Gerald J. ;
Wester, Sara T. ;
Schiffman, Jade S. ;
Tang, Rosa A. ;
Fowler, Brian ;
Fleming, James ;
Smith, Terry J. .
JOURNAL OF NEURO-OPHTHALMOLOGY, 2021, 41 (04) :461-468
[8]   Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment [J].
Douglas, Raymond S. ;
Kahaly, George J. ;
Ugradar, Shoaib ;
Elflein, Heike ;
Ponto, Katharina A. ;
Fowler, Brian T. ;
Dailey, Roger ;
Harris, Gerald J. ;
Schiffman, Jade ;
Tang, Rosa ;
Wester, Sara ;
Jain, Amy Patel ;
Marcocci, Claudio ;
Marino, Michele ;
Antonelli, Alessandro ;
Eckstein, Anja ;
Fuhrer-Sakel, Dagmar ;
Salvi, Mario ;
Sile, Saba ;
Francis-Sedlak, Megan ;
Holt, Robert J. ;
Smith, Terry J. .
OPHTHALMOLOGY, 2022, 129 (04) :438-449
[9]   Insulin-Like Growth Factor 1 on the Maintenance of Ribbon Synapses in Mouse Cochlear Explant Cultures [J].
Gao, Li ;
Kita, Tomoko ;
Katsuno, Tatsuya ;
Yamamoto, Norio ;
Omori, Koichi ;
Nakagawa, Takayuki .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
[10]   Association of Hearing Loss With Hospitalization and Burden of Disease in Older Adults [J].
Genther, Dane J. ;
Frick, Kevin D. ;
Chen, David ;
Betz, Joshua ;
Lin, Frank R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (22) :2322-2324
12